SenesTech (NASDAQ:SNES) announced its earnings results on Tuesday. The company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.01, Bloomberg Earnings reports. The firm had revenue of $0.02 million during the quarter. SenesTech had a negative return on equity of 186.65% and a negative net margin of 3,908.08%.
Shares of SNES opened at $1.41 on Wednesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.76 and a current ratio of 3.83. SenesTech has a 1 year low of $0.55 and a 1 year high of $1.95. The company has a market capitalization of $38.72 million, a PE ratio of -2.23 and a beta of 1.76. The stock’s 50-day moving average is $1.50.
Separately, ValuEngine raised SenesTech from a “hold” rating to a “buy” rating in a research report on Friday, June 28th.
In other SenesTech news, CEO Kenneth S. Siegel acquired 696,296 shares of the business’s stock in a transaction dated Tuesday, July 16th. The shares were acquired at an average price of $1.35 per share, for a total transaction of $939,999.60. Following the acquisition, the chief executive officer now directly owns 702,558 shares of the company’s stock, valued at approximately $948,453.30. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 10.91% of the stock is currently owned by company insiders.
A number of institutional investors have recently made changes to their positions in the stock. Virtu Financial LLC increased its holdings in SenesTech by 87.4% during the 1st quarter. Virtu Financial LLC now owns 56,447 shares of the company’s stock valued at $69,000 after acquiring an additional 26,322 shares in the last quarter. Meitav Dash Investments Ltd. purchased a new stake in SenesTech in the first quarter valued at approximately $81,000. First Interstate Bank acquired a new position in SenesTech during the second quarter valued at approximately $31,000. MRA Associates USA LLC acquired a new position in SenesTech during the second quarter valued at approximately $46,000. Finally, Bank of New York Mellon Corp acquired a new position in SenesTech during the second quarter valued at approximately $62,000. 6.93% of the stock is currently owned by institutional investors and hedge funds.
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.
Featured Article: Price-Sales Ratio
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.